- Report: Specialty pharmacy to account for half of all prescription revenue by 2018
- Revlon names new president, CEO
- Walgreens' Greg Wasson featured on 'Mad Money'
- Drug Channels: Express Scripts, CVS Caremark and Walgreens top players in specialty pharmacy
- Reuters: Safeway a target for possible buyout
ST. LOUIS — In an amendment dated Nov. 7 and filed to the Securities Exchange Commission on Tuesday, Express Scripts reduced its termination fee by 32% to $650 million. The termination fee is paid to one company when the other terminates the merger agreement.
The change was made to settle lawsuits against Medco accusing the company of selling itself too cheaply to Express Scripts, according to a research note by Bank of America Merrill Lynch analysts published on Tuesday, as reported by the New York Times. The lower fee may create more interest among rivals hoping to compete for Medco, the analysis concluded.